Literature DB >> 16200611

Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factor.

Timothy R D J Radstake1, Fred C G J Sweep, Paco Welsing, Barbara Franke, Sita H H M Vermeulen, Anneke Geurts-Moespot, Thierry Calandra, Rachelle Donn, Piet L C M van Riel.   

Abstract

OBJECTIVE: To study whether genetic variants of macrophage migration inhibitory factor (MIF), the MIF -173G>C and CATT(5-8) alleles, are associated with disease severity and levels of circulating MIF in patients with rheumatoid arthritis (RA).
METHODS: Genotyping was performed in patients with early RA and in healthy controls. Demographic data, disease activity, and outcome measurements were compared between patients with and without the MIF variants. MIF -173G>C and CATT(5-8) polymorphisms were genotyped, and a newly developed enzyme-linked immunosorbent assay for human MIF was used. Allele and genotype distributions of the MIF -173G>C and CATT(5-8) polymorphisms were compared between patients and controls by chi-square test. Multiple regression analysis was performed to assess the independence of the MIF functional genetic variants as risk factors for radiologic joint damage.
RESULTS: Genotyping of the -173G>C and CATT(5-8) polymorphisms of MIF in RA patients and healthy individuals (n = 277 each) revealed similar frequencies of genotypes and haplotypes in both groups. No significant differences in demographic or clinical features were observed between RA patients carrying the MIF -173C allele or the MIF CATT7 allele or both and non-carrier RA patients. Radiologic joint damage was significantly higher in patients carrying risk alleles of the MIF -173G>C or the MIF CATT(5-8) functional variants. No synergistic effects between both genetic variants were observed. Multivariate regression analysis revealed that presence of the MIF -173C/C and MIF CATT(7/7) genotypes and having 1 MIF -173C allele were independent prognostic variables. Carriership of the MIF -173C allele (P = 0.002) or MIF CATT7 allele (P = 0.004) was associated with significantly higher circulating MIF levels compared with those in subjects having none of the risk-conferring alleles, and greater circulating MIF levels correlated with more severe radiologic joint damage (r = 0.64, P = 0.001).
CONCLUSION: The MIF polymorphisms are not associated with RA susceptibility but are associated with high levels of radiologic joint damage. High circulating MIF levels were shown to correlate strongly with radiologic joint damage, suggesting that MIF expression is genetically determined and can be used as a novel prognostic tool in RA.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16200611     DOI: 10.1002/art.21285

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  84 in total

Review 1.  D-dopachrome tautomerase (D-DT or MIF-2): doubling the MIF cytokine family.

Authors:  Melanie Merk; Robert A Mitchell; Stefan Endres; Richard Bucala
Journal:  Cytokine       Date:  2012-04-14       Impact factor: 3.861

Review 2.  Macrophage migration inhibitory factor (MIF): a promising biomarker.

Authors:  Gerrit Grieb; Melanie Merk; Jürgen Bernhagen; Richard Bucala
Journal:  Drug News Perspect       Date:  2010-05

3.  Influence of MIF, CD40, and CD226 polymorphisms on risk of rheumatoid arthritis.

Authors:  Ruiping Liu; Nanwei Xu; Xinxiang Wang; Li Shen; Gongyin Zhao; Hui Zhang; Weimin Fan
Journal:  Mol Biol Rep       Date:  2012-06       Impact factor: 2.316

4.  Macrophage migration inhibitory factor and its genetic association with arthritis: a work in progress.

Authors:  Timothy R D J Radstake; Richard Bucala
Journal:  Curr Rheumatol Rep       Date:  2007-10       Impact factor: 4.592

5.  Role of Macrophage Migration Inhibitory Factor in Granulomatosis With Polyangiitis.

Authors:  Antoine G Sreih; Rana Ezzedine; Lin Leng; Juan Fan; Jie Yao; Duncan Reid; Marta Piecychna; Simon Carette; David Cuthbertson; Paul Dellaripa; Gary S Hoffman; Nader A Khalidi; Curry L Koening; Carol A Langford; Alfred Mahr; Carol A McAlear; Kathleen Maksimowicz-Mckinnon; Paul A Monach; Philip Seo; Ulrich Specks; E William St Clair; John H Stone; Steven R Ytterberg; Jeffrey Edberg; Peter A Merkel; Richard Bucala
Journal:  Arthritis Rheumatol       Date:  2018-10-22       Impact factor: 10.995

6.  Polymorphisms in the macrophage migration inhibitory factor gene and bone loss in postmenopausal women.

Authors:  Maria Swanberg; Fiona McGuigan; Kaisa K Ivaska; Paul Gerdhem; Ulf H Lerner; Richard Bucala; George Kuchel; Anne Kenny; Kristina Akesson
Journal:  Bone       Date:  2010-05-12       Impact factor: 4.398

7.  Macrophage migration inhibitory factor is essential for osteoclastogenic mechanisms in vitro and in vivo mouse model of arthritis.

Authors:  Ran Gu; Leilani L Santos; Devi Ngo; HuaPeng Fan; Preetinder P Singh; Gunter Fingerle-Rowson; Richard Bucala; Jiake Xu; Julian M W Quinn; Eric F Morand
Journal:  Cytokine       Date:  2015-01-31       Impact factor: 3.861

8.  Association of the macrophage migration inhibitory factor promoter polymorphisms with benign lymphoepithelial lesion of lacrimal gland.

Authors:  Qin-Jian Li; Peng-Xiang Zhao; Xu-Juan Zhang; Yang Yi; Dan-Ying Cheng; Jian-Min Ma; Xue-Mei Ma
Journal:  Int J Ophthalmol       Date:  2017-08-18       Impact factor: 1.779

9.  A Macrophage Migration Inhibitory Factor Polymorphism Is Associated with Autoimmune Hepatitis Severity in US and Japanese Patients.

Authors:  David N Assis; Hiroki Takahashi; Lin Leng; Mikio Zeniya; James L Boyer; Richard Bucala
Journal:  Dig Dis Sci       Date:  2016-10-01       Impact factor: 3.199

10.  Influence of the MIF polymorphism -173G > C on Turkish postmenopausal women with osteoporosis.

Authors:  A Z Ozsoy; N Karakus; S Tural; S Yigit; N Kara; G Alayli; M K Tumer; O Kuru
Journal:  Z Rheumatol       Date:  2018-09       Impact factor: 1.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.